FSSAI Withdraws Order To Declare ‘Best Before Date’ On Loose Sweets

New Delhi: The Food Safety and Standards Authority of India (FSSAI) has withdrawn a September 2020 order that made it mandatory to declare ‘Best Before’ date on containers and trays of non-packaged loose sweets.
The directive for withdrawal was issued on November 7, 2023, barely days before Diwali.
The FSSAI said that the original order was issued in parity with the declaration required for packaged food products under the erstwhile Food Safety Standards (Packaging and Labelling) Regulations of 2011.
It said now, considering that the Food Safety Standards (Packaging and Labelling) Regulations 2011 have been superseded by the Food Safety and Standards (Labelling and Display) Regulations 2020, the said directive has been reviewed and it is observed that the same requires further deliberations by the concerned scientific panel regarding the declaration of date marking on non-packaged or loose food products.
“In view of the above, the aforesaid direction dated September 25, 2020, issued stands hereby withdrawn till further decision by the FSSAI in the matter,” the regulator said.
However, it said that food business operators may declare ‘Best Before Date’ on non-packaged sweet or loose sweet containers on a voluntary or optional basis.
Consumption of sweets and food items goes manifold during Diwali and the accompanying festivities during this time of the year.

Related Posts

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

CHENNAI: The Madras High Court on Friday dismissed a petition seeking to quash a First Information Report (FIR) registered against Puducherry-based pharmaceutical entities accused of manufacturing and distributing counterfeit medicines…

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

Chhattisgarh: Riding on policy reforms that earned it the top rank among large states in NITI Aayog’s Investment Friendliness Index 2026 for Regulatory Ease and Institutional Environment, Chhattisgarh has received…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

Pharma companies in a flux over Trump’s 200% tariff move on generics

Pharma companies in a flux over Trump’s 200% tariff move on generics

Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’